These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 25786083)

  • 1. Hepatic arteriolosclerosis: a small-vessel complication of diabetes and hypertension.
    Balakrishnan M; Garcia-Tsao G; Deng Y; Ciarleglio M; Jain D
    Am J Surg Pathol; 2015 Jul; 39(7):1000-9. PubMed ID: 25786083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinicopathologic features of hepatic diabetic microangiopathy].
    Wang Z; He QH; Yang L; Pang JX; Sun MJ; Yu Q; Liu DG
    Zhonghua Bing Li Xue Za Zhi; 2012 Oct; 41(10):676-80. PubMed ID: 23302309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetic hepatosclerosis: another diabetes microvascular complication?
    King RJ; Harrison L; Gilbey SG; Santhakumar A; Wyatt J; Jones R; Bodansky HJ
    Diabet Med; 2016 Feb; 33(2):e5-7. PubMed ID: 26315331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetic microangiopathy in the liver: an autopsy study of incidence and association with other diabetic complications.
    Hudacko RM; Sciancalepore JP; Fyfe BS
    Am J Clin Pathol; 2009 Oct; 132(4):494-9. PubMed ID: 19762525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic hepatosclerosis: a 10-year autopsy series.
    Chen G; Brunt EM
    Liver Int; 2009 Aug; 29(7):1044-50. PubMed ID: 19141031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic hepatosclerosis: diabetic microangiopathy of the liver.
    Harrison SA; Brunt EM; Goodman ZD; Di Bisceglie AM
    Arch Pathol Lab Med; 2006 Jan; 130(1):27-32. PubMed ID: 16390234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance and hypertension in patients with type 1 diabetes.
    Chillarón JJ; Sales MP; Flores-Le-Roux JA; Murillo J; Benaiges D; Castells I; Goday A; Cano JF; Pedro-Botet J
    J Diabetes Complications; 2011; 25(4):232-6. PubMed ID: 21601483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parental history of hypertension and parental history of diabetes and microvascular complications in insulin-dependent diabetes mellitus: the EURODIAB IDDM Complications Study.
    Roglic G; Colhoun HM; Stevens LK; Lemkes HH; Manes C; Fuller JH
    Diabet Med; 1998 May; 15(5):418-26. PubMed ID: 9609365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between serum ferritin, hepatic iron staining, diabetes mellitus and fibrosis progression in patients with chronic hepatitis C.
    D'Souza RF; Feakins R; Mears L; Sabin CA; Foster GR
    Aliment Pharmacol Ther; 2005 Mar; 21(5):519-24. PubMed ID: 15740534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of osteoprotegerin with peripheral artery disease in patients with type 2 diabetes.
    Esteghamati A; Aflatoonian M; Rad MV; Mazaheri T; Mousavizadeh M; Nakhjavani M; Noshad S
    Arch Cardiovasc Dis; 2015; 108(8-9):412-9. PubMed ID: 26184866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cardiovascular disease in patients with type 1 and type 2 diabetes in Spain].
    Ortega E; Amor AJ; Rojo-Martínez G; Castell C; Giménez M; Conget I
    Med Clin (Barc); 2015 Sep; 145(6):233-8. PubMed ID: 25561182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mechanisms of development of diabetic macroangiopathy].
    Saltykov BB
    Arkh Patol; 2001; 63(2):21-6. PubMed ID: 11392087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of elevated serum uric acid with coronary heart disease in diabetes mellitus.
    Rathmann W; Hauner H; Dannehl K; Gries FA
    Diabete Metab; 1993; 19(1 Pt 2):159-66. PubMed ID: 8314420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Atherogenic dyslipidemia in patients with type 1 diabetes mellitus].
    Chillarón JJ; Sales MP; Flores Le-Roux JA; Castells I; Benaiges D; Sagarra E; Pedro-Botet J
    Med Clin (Barc); 2013 Dec; 141(11):465-70. PubMed ID: 23790581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of microangiopathy in type 2 diabetes mellitus patients with or without chronic hepatitis C: Results of a retrospective long-term controlled cohort study.
    Coppo C; Bonfanti D; Bo S; Giordanino C; Gallo M; Cococcia S; Ciccone G; Smedile A; Ciancio A; Bugianesi E; Fagoonee S; Pellicano R; Rizzetto M; Saracco GM
    Dig Liver Dis; 2015 May; 47(5):405-10. PubMed ID: 25733341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevalence and risk factors of hepatic steatosis in patients with chronic hepatitis B].
    Shi JP; Fan JG; Wu R; Gao XQ; Zhang L; Wang H
    Zhonghua Gan Zang Bing Za Zhi; 2008 Jul; 16(7):519-23. PubMed ID: 18647531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and natural history of histologically proven chronic liver disease in a longitudinal cohort of patients with type 1 diabetes.
    Harman DJ; Kaye PV; Harris R; Suzuki A; Gazis A; Aithal GP
    Hepatology; 2014 Jul; 60(1):158-68. PubMed ID: 24585431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of non-alcoholic fatty liver disease on chronic hepatitis B.
    Bondini S; Kallman J; Wheeler A; Prakash S; Gramlich T; Jondle DM; Younossi ZM
    Liver Int; 2007 Jun; 27(5):607-11. PubMed ID: 17498244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated concentrations of circulating adhesion molecules and their association with microvascular complications in insulin-dependent diabetes mellitus.
    Fasching P; Veitl M; Rohac M; Streli C; Schneider B; Waldhäusl W; Wagner OF
    J Clin Endocrinol Metab; 1996 Dec; 81(12):4313-7. PubMed ID: 8954033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationships among microalbuminuria, insulin resistance and renal-cardiac complications in insulin dependent and non insulin dependent diabetes.
    Nosadini R; Brocco E
    Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 2():1-7. PubMed ID: 9288531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.